Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy.
about
Curcumin and diabetes: a systematic reviewHistone Acetylation and Its Modifiers in the Pathogenesis of Diabetic NephropathyRisk factors and primary prevention trials for type 1 diabetesEpigenetic diet: impact on the epigenome and cancerAcetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC)17-β Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1/AMPK/H3 acetylationRenal failure increases cardiac histone h3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes.Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLCEpigenetic mechanisms in the development of type 2 diabetes.Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.Epigenetic targets of bioactive dietary components for cancer prevention and therapy.Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesPotential of epigenetic therapies in non-cancerous conditions."Curcumin, the King of Spices": Epigenetic Regulatory Mechanisms in the Prevention of Cancer, Neurological, and Inflammatory Diseases.Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic ratsTranscription factors in the pathogenesis of diabetic nephropathy.C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21Epigenetics in autoimmune diseases with focus on type 1 diabetes.Curcumin in inflammatory diseases.Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.An overview of epigenetics in Chinese medicine researches.Elevated histone acetylations in Müller cells contribute to inflammation: a novel inhibitory effect of minocycline.Curcumin improves expression of SCF/c-kit through attenuating oxidative stress and NF-κB activation in gastric tissues of diabetic gastroparesis rats.Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling.Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10.Andrographolide suppresses high glucose-induced fibronectin expression in mesangial cells via inhibiting the AP-1 pathway.Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome.Epigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes.Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective.TNF-α, IL-6 and IL-10 expressions, responsible for disparity in action of curcumin against cisplatin-induced nephrotoxicity in rats.Dietary supplementation of curcumin augments heat stress tolerance through upregulation of nrf-2-mediated antioxidative enzymes and hsps in Puntius sophore.Curcumin protects against fructose-induced podocyte insulin signaling impairment through upregulation of miR-206.Alteration in inflammatory/apoptotic pathway and histone modifications by nordihydroguaiaretic acid prevents acute pancreatitis in swiss albino mice.Pulmonary fibrotic response to inhalation of ZnO nanoparticles and toluene co-exposure through directed flow nose only exposure chamber.
P2860
Q21284809-0D0892E4-8A91-46B0-B710-18BAC515B742Q26744442-82D01788-857C-448E-83E4-AE24C1C4E9C6Q27005625-39CA430D-7781-4FB8-BACD-8EC6208B2358Q27022002-9D70EAFF-9FDB-478F-B536-5A71A0942ED8Q28579534-760DEF5F-3452-46AA-A4B6-6A607679CCB0Q28582839-375DE0F2-EC04-41C2-84E2-A947F4EC23BDQ33703612-3FFDD9E6-69B2-447C-83F2-8675C77BB05CQ33745769-B398F33E-D9A3-4CBA-B9B5-CD5720A31187Q33767089-9B7CBCED-7623-400C-88F9-DC2350B57B10Q34279875-D4754B99-1DA1-41A8-BAF4-068C911665FAQ34508252-E1217D04-0EAE-48AC-A44F-F47DCE18200BQ34594807-72E25E79-74AB-4382-B29C-5ACCBDCF52BEQ34742578-3632A855-6F34-4447-BED1-7EDC93AA0B72Q36131769-08106057-62EF-4D7F-8255-2E90FAF49822Q36159004-7A7E3994-F54E-4C4D-BD22-0041E11D6CE3Q37461601-44FDBF63-5774-4008-95A4-0C3DCAF23A4BQ37603152-199DFA69-952B-43D7-BE3D-0818298DE34AQ38062497-FBA1538A-3C4A-4178-AFA7-D2394A70537EQ38071037-765D6DA4-23C8-43FE-B9F1-433D124F3D68Q38818485-D02F88DF-77D7-4D9D-ACFA-F4AE60BA1824Q39045130-E58B2234-A784-4A93-B2E6-3FF4BF0474EEQ39292617-64E63BA6-1359-408B-9FF6-2DF560CF8C9EQ39938556-AF46A359-8262-45F0-96C8-51C2DD95C0AFQ42177918-1D628370-CB45-459B-A662-B0224652D652Q43196259-4DCE249E-D6E8-473D-8E64-C31CC3DFD622Q43928331-5FFE5868-3A5F-4EC3-BBC4-E202788B2061Q44333090-516852A2-A1CA-4E92-A8C4-234DCDB5FCA3Q44370140-44F5D938-8F7E-4433-B189-2B39064AB9F7Q47294278-7020D9A6-6F16-4401-A90A-440836892906Q47840966-14D08C3C-AC0F-442D-985A-8BDE257F0E16Q51094890-D7E3D729-9E15-4ECE-9228-31BF9B087AAEQ53336518-28D7B13B-CB15-4F3A-BF33-0D0B6BB590D2Q54351822-7E94F4BD-0334-45C0-9F3C-D05808DE58CAQ54567527-CAD29B3F-8C1F-417F-9147-B68188B81C67
P2860
Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Change in post-translational m ...... d type I diabetic nephropathy.
@ast
Change in post-translational m ...... d type I diabetic nephropathy.
@en
type
label
Change in post-translational m ...... d type I diabetic nephropathy.
@ast
Change in post-translational m ...... d type I diabetic nephropathy.
@en
prefLabel
Change in post-translational m ...... d type I diabetic nephropathy.
@ast
Change in post-translational m ...... d type I diabetic nephropathy.
@en
P2093
P2860
P356
P1476
Change in post-translational m ...... ed type I diabetic nephropathy
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0707666
P407
P577
2008-01-21T00:00:00Z